A phase 2 study evaluating the effects of 24 weeks of IMM-124e in patients with biopsy-proven MASH showed a reduction in AST and ALT but no change in hepatic fat content (NCT02316717)
Georges University School of Medicine, her medical school
Vrijens B et al
Several biotech companies are developing intra-articular formulations of AOD-9604 for osteoarthritis
RETAILER RESPONSES Retailers have said consumers are shopping more often, with smaller basket sizes, and their shift toward fresh, lean protein and less processed foods has been ongoing for several years, which makes it difficult to distinguish the exact GLP-1 impact
But for that purpose, knowing how these medications work, their benefits, side effects, the most effective option, etc., is vital